CV Therapeutics

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

CV6 Therapeutics (NI) Ltd

This biotechnology company develops small molecule drugs that enhance chemotherapy and treat inflammatory diseases for patients with cancer and rheumatoid arthritis.

Rapidscan

This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Revier Therapeutics

This company develops orally available small molecules targeting class IIa histone deacetylases to treat patients with heart failure and atherosclerotic cardiovascular diseases.

Arvada Therapeutics

This biotechnology company develops large-molecule therapeutics to treat patients suffering from abnormal heart rhythms and arrhythmogenic right ventricular cardiomyopathy.

Braveheart Bio

This biopharmaceutical company develops small-molecule therapeutics to treat patients with hypertrophic cardiomyopathy and other serious cardiovascular conditions.

Edgewise Therapeutics

This biopharmaceutical company develops small molecule therapies for patients with serious cardiovascular diseases and musculoskeletal conditions like Duchenne and Becker muscular dystrophy.